Quingestanol

Last updated
Quingestanol
Quingestanol structure.svg
Clinical data
Other namesNorethisterone 3-cyclopentyl enol ether; 3-(Cyclopentyloxy)-17α-ethynylestra-3,5-dien-17β-ol
Drug class Progestin; Progestogen
ATC code
Identifiers
  • (8R,9S,10R,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.031.078 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C25H34O2
Molar mass 366.545 g·mol−1
3D model (JSmol)
  • O(\C4=C\C3=C\C[C@@H]2[C@H](CC[C@]1(C)[C@@](C#C)(O)CC[C@H]12)[C@H]3CC4)C5CCCC5
  • InChI=1S/C25H34O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,8,16,18,20-23,26H,4-7,9-15H2,2H3/t20-,21+,22+,23-,24-,25-/m0/s1
  • Key:PCJFRMOEZQQSAX-AIOSZGMZSA-N

Quingestanol (INN Tooltip International Nonproprietary Name, BAN Tooltip British Approved Name), also known as norethisterone 3-cyclopentyl enol ether, is a progestin of the 19-nortestosterone group which was never marketed. [1] It is a prodrug of norethisterone. [2] [3] An acylated derivative, quingestanol acetate, is used as a pharmaceutical drug. [1]

See also

References

  1. 1 2 Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1721. ISBN   978-0-412-46630-4 . Retrieved 12 May 2012.
  2. Raynaud JP, Ojasoo T (1986). "The design and use of sex-steroid antagonists". J. Steroid Biochem. 25 (5B): 811–33. doi:10.1016/0022-4731(86)90313-4. PMID   3543501. Similar androgenic potential is inherent to norethisterone and its prodrugs (norethisterone acetate, ethynodiol diacetate, lynestrenol, norethynodrel, quingestanol).
  3. Di Carlo FJ, Loo JC, Aceto T, Zuleski FR, Barr WH (1974). "Quingestanol acetate metabolism in women". Pharmacology. 11 (5): 287–303. doi:10.1159/000136501. PMID   4853997.